Skip to content

In the BioHarmony Drug Report Database

Rapacuronium

Raplon (rapacuronium) is a small molecule pharmaceutical. Rapacuronium was first approved as Raplon on 1999-08-18.
Trade Name Raplon
Common Name Rapacuronium
Indication
Drug Class Quaternary ammonium derivatives: neuromuscular blocking agents
Rapacuronium
Get full access now